CUSIP: 20600T108
Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,933,518
-
Share change
-
-1,073,205
-
Total reported value
-
$24,058,000
-
Put/Call ratio
-
144%
-
Price per share
-
$6.12
-
Number of holders
-
33
-
Value change
-
-$8,762,337
-
Number of buys
-
14
-
Number of sells
-
22
Institutional Holders of CONATUS PHARMACEUTICALS INC - COM (CNAT) as of Q3 2014
As of 30 Sep 2014,
CONATUS PHARMACEUTICALS INC - COM (CNAT) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,933,518 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP LLC, AXA, Polar Capital LLP, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, BlackRock Advisors LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, Weiss Multi-Strategy Advisers LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.